Worldwide Clinical Trials Expert to Present at Outsourcing in Clinical Trials Europe

Jeanine Ronniger of Worldwide Clinical Trials to discuss how sponsors and CROs can work together to share risk, strengthen their bond and improve study success

May 16, 2016, 09:00 ET from Worldwide Clinical Trials

MORRISVILLE, North Carolina, May 16, 2016 /PRNewswire/ --

Jeanine Ronniger, director of project management at Worldwide Clinical Trials, will present at the 6th Annual Outsourcing in Clinical Trials Europe (OCT-EU) conference, being held May 17 and 18 in Paris, France. Ronniger, who has more than 16 years of experience in clinical trials project management, will present to industry peers on how sponsors and CROs can work together to share risk, strengthen their bond and improve study success on Wednesday, May 18 at 11:30 a.m.

"The relationship between a sponsor and CRO is critical to the successful execution of a clinical trial," explains Ronniger. "Effective planning and risk sharing, unique governance models, open and ongoing communication, and frequent measurement and reporting - these things are all key to achieving positive study outcomes. I will explore how to put these strategies into practice to ensure their study programs are delivered to the highest quality, within budget and to timescales."

In addition to Ronniger's presentation, experts from the Worldwide Clinical Trials team will be available at booth #9 throughout OCT-EU to discuss attendees' individual drug development challenges as well as their concerns and needs across a range of therapeutic areas, including neuroscience, cardiovascular disease, inflammatory disorders, and rare disease.

OCT-EU offers two days of interactive sessions focused on building partnerships and optimizing operational strategies within clinical trials. For further information about OCT-EU, visit http://www.arena-international.com/octeurope/

Connect with Worldwide Clinical Trials: 

About Worldwide Clinical Trials  
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.Worldwide.com .

SOURCE Worldwide Clinical Trials